Amgen Inc.
AMGN
$307.31
$7.012.33%
| Weiss Ratings | AMGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Good | |||
| Risk Index | Fair | |||
| Risk Grade | C+ | |||
| Reward Grade | B- | |||
| Rating Factors | AMGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Good | |||
| Growth Index | Fair | |||
| Efficiency Index | Excellent | |||
| Solvency Index | Excellent | |||
| Total Return Index | Fair | |||
| Volatility Index | Fair | |||
| Beta / Standard Deviation | AMGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.41 | |||
| Price History | AMGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 12.63% | |||
| 30-Day Total Return | 10.48% | |||
| 60-Day Total Return | 5.77% | |||
| 90-Day Total Return | 7.98% | |||
| Year to Date Total Return | 4.71% | |||
| 1-Year Total Return | 33.78% | |||
| 2-Year Total Return | 32.12% | |||
| 3-Year Total Return | 25.57% | |||
| 5-Year Total Return | 94.18% | |||
| 52-Week High % Change | -8.92% | |||
| 52-Week Low % Change | 41.84% | |||
| Price | AMGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $329.72 | |||
| 52-Week Low Price | $211.71 | |||
| 52-Week Low Price (Date) | Jun 01, 2023 | |||
| 52-Week High Price (Date) | Feb 05, 2024 | |||
| Valuation | AMGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 166.99B | |||
| Enterprise Value | 221.30B | |||
| Price/Earnings (TTM) | 24.91 | |||
| Earnings Per Share (TTM) | 12.49 | |||
| Earnings Per Share Growth | -52.37% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 5.96 | |||
| Price/Book (Q) | 26.74 | |||
| Enterprise Value/Revenue (TTM) | 7.29 | |||
| Price | $311.29 | |||
| Enterprise Value/EBITDA (TTM) | 18.50 | |||
| Enterprise Value/EBIT | 30.45 | |||
| Market Cap Category | Large Cap | |||
| Dividends and Shares | AMGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 536.00M | |||
| Dividend Yield | 2.78% | |||
| Div. Per Share (Most Recent) | $2.25 | |||
| Dividend Per Share (TTM) | $8.64 | |||
| Payout Ratio (TTM) | 122.96% | |||
| Dividend Per Share (Most Recent) | $2.25 | |||
| Company Info | AMGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 805 447 1000 | |||
| Address | One Amgen Center Drive Thousand Oaks, CA 91320-1799 | |||
| Website | www.amgen.com | |||
| Country | United States | |||
| Year Founded | 1980 | |||
| Profitability | AMGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 23.95% | |||
| Profit Margin | 12.74% | |||
| Management Effectiveness | AMGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 4.87% | |||
| Return on Equity | 72.57% | |||
| Income Statement | AMGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 28.18B | |||
| Total Revenue (TTM) | 29.53B | |||
| Revenue Per Share | $55.10 | |||
| Gross Profit (TTM) | 19.60B | |||
| EBITDA (TTM) | 11.65B | |||
| EBIT (TTM) | 7.08B | |||
| Net Income (TTM) | 3.76B | |||
| Net Income Avl. to Common (TTM) | 3.76B | |||
| Total Revenue Growth (Q YOY) | 21.98% | |||
| Earnings Growth (Q YOY) | -103.98% | |||
| EPS Diluted (TTM) | 7.00 | |||
| EPS Diluted Growth (Q YOY) | -103.99% | |||
| Balance Sheet | AMGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 9.71B | |||
| Cash Per Share (Q) | $18.11 | |||
| Total Current Assets (Q) | 28.03B | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 5.02B | |||
| Current Ratio (Q) | 1.422 | |||
| Book Value Per Share (Q) | $9.36 | |||
| Total Assets (Q) | 92.98B | |||
| Total Current Liabilities (Q) | 19.71B | |||
| Total Debt (Q) | 64.02B | |||
| Total Liabilities (Q) | 87.96B | |||
| Total Common Equity (Q) | 5.02B | |||
| Cash Flow | AMGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -27.78B | |||
| Cash from Financing (TTM) | -2.17B | |||
| Net Change in Cash (TTM) | -21.85B | |||
| Levered Free Cash Flow (TTM) | 3.79B | |||
| Cash from Operations (TTM) | 8.10B | |||
